IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Myriad Genetics Inc. SupplierIQ Procurement Profile
Myriad Genetics, Inc. is a molecular diagnostic testing and precision medicine company that develops and commercializes molecular tests to assess disease or disease progression and guide treatment decisions across oncology, women's health, and pharmacogenomics. Its product portfolio includes MyRisk™ hereditary cancer test, BRACAnalysis CDx® germline companion diagnostic test, MyChoice® CDx companion diagnostic test, Prolaris® prostate cancer prognostic test, EndoPredict® breast cancer prognostic test, Precise™ Tumor Molecular profile test, Prequel® prenatal screen, Foresight® carrier screen, SneakPeek® early gender DNA test, and GeneSight® psychotropic mental health medication test. It sells its tests in the US and Japan through its direct sales force and internationally through indirect sales channels. The firm was incorporated in Delaware on November 6, 1992. Its headquarters are located in Salt Lake City, Utah.
Access this data your way
The SupplierIQ analysis is available in multiple formats to fit seamlessly into your workflow.
What’s included in this SupplierIQ Profile
IBISWorld's SupplierIQ profile covering Myriad Genetics Inc. includes financial statements, products & service markets, competitive position and key financial health ratios.
Company Snapshot
What’s covered in this SupplierIQ Profile?
This SupplierIQ profile on Myriad Genetics Inc. covers the company’s financial statements, products & service markets, competitive position and key financial health ratios. Myriad Genetics Inc., trading as Myriad, is a public company with 2.7k employees.
What industries does Myriad Genetics Inc. operate in?
Myriad Genetics Inc. primarily operates in In-Vitro Diagnostic Substance Manufacturing, as well as in Diagnostic & Medical Laboratories in the US.
Product & Service Markets
What’s included in the Product & Service Markets chapter?
The Product & Service Markets chapter provides a breakdown of Myriad Genetics Inc.’s key product and service segments, organized by standardized industry classifications like NAICS. It includes their market share in each of these markets with market share trends and insights.
Competitive Position
What’s included in the Competitive Position chapter?
The Competitive Position chapter covers Myriad Genetics Inc.’s performance relative to competitors in each of the products and service markets the company operates in. This includes a detailed competitor matrix comparing the market share, return on assets, return on equity, pricing power and competitive outlook. There are qualitative insights and a detailed SWOT analysis included for each product and service market.
Income Statement
What’s included in the Income Statement chapter?
The Income Statement chapter includes datasets covering Myriad Genetics Inc.’s historical financial performance. Line items include revenue, cost of sales, gross margins, general and administrative costs, research and development costs, depreciation, interest and taxes. This is available in current and historical datasets.
Balance Sheet
What’s included in the Balance Sheet chapter?
The Balance Sheet chapter includes datasets covering Myriad Genetics Inc.’s historical financial health. Current asset and non-current asset accounts include line items like cash, receivables, inventories, property, plant and equipment, investments, goodwill. Current liabilities and non-current liabilities accounts include line items like accounts payable, debts, provisions and lease liabilities. The equity accounts include line items like paid-in capital, retained earnings, employee stock option plans and treasury stock. This is available in current and historical datasets.
Cash Flows
What’s included in the Cash Flows chapter?
The Cash Flows chapter includes detailed line item accounts covering Myriad Genetics Inc.’s operating cash flow activities, financing cash flow activities and investing cash flow activities. This is available in current and historical datasets.
Ratios
What’s included in the Ratios chapter?
The Ratios chapter covers key financial metrics like the operating margin, gross margin, return on equity, return on assets, current ratio, quick ratio, EBIT margins, EBITDA margins, debt ratio, equity ratio and debt to equity ratios. This is available in current and historical datasets.
Trusted by industry professionals
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Frequently Asked Questions
What is the 2025 revenue for Myriad Genetics Inc.?
According to the 2026 IBISWorld ProcurementIQ report, Myriad Genetics Inc. generated $824.5m in revenue.
Who are Myriad Genetics Inc.’s main competitors?
The 2026 ProcurementIQ report benchmarks Myriad Genetics Inc. against its top competitors across execution score, operational capabilities, pricing power, and market share.
What is Myriad Genetics Inc.’s EBITDA margin?
Myriad Genetics Inc.’s EBITDA margin is reported across a 7-year period in the 2026 IBISWorld ProcurementIQ report. The report includes a full income statement breakdown.
What markets does Myriad Genetics Inc. operate in?
The 2026 report identifies all NAICS-coded product and service markets Myriad Genetics Inc. participates in, including market share, concentration, profitability trends, and average vendor risk ratings.
How many employees does Myriad Genetics Inc. have?
The 2026 ProcurementIQ report lists Myriad Genetics Inc.’s employee count and benchmarks workforce size against key competitors to assess relative operational capacity.
Cut through the noise with intelligence you can trust
